SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-067719
Filing Date
2022-06-02
Accepted
2022-06-02 17:23:58
Documents
14
Period of Report
2022-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2217514d1_8k.htm   iXBRL 8-K 29338
2 EXHIBIT 10.1 tm2217514d1_ex10-1.htm EX-10.1 927110
6 GRAPHIC tm2217514d1_ex10-1img001.jpg GRAPHIC 6575
  Complete submission text file 0001104659-22-067719.txt   1336460

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akya-20220601.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akya-20220601_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akya-20220601_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2217514d1_8k_htm.xml XML 3718
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 22992038
SIC: 3826 Laboratory Analytical Instruments